|
|||||
       |
A developer of messenger RNA therapies for respiratory and rare diseases says it received clearance to begin a clinical trial in the U.K. for an inhaled treatment for viral lung conditions. . . . → Read More: Trial Set to Test Inhaled mRNA for Viral Infections 
Researchers from university labs in the U.K. are developing models of brain cell interactions using a company’s synthetic human cells derived from stem cells. . . . → Read More: Academic, Industry Labs to Build Brain Cell Models 
A company formed earlier this year is developing precision treatments for bacteria resistant to conventional antibiotics, and raising £4.3 million ($US 5.4 million) in seed funds. . . . → Read More: Start-Up Developing Precision Antibiotics for Resistant Bacteria  Comments are closed  Finance, New products  biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, life sciences, pharmaceuticals, physical sciences, U.K., university, venture capital 
A developer of treatments for Alzheimer’s disease that seeks to improve the condition of the brain’s support cells is raising £48 million ($US 61 million) in its first venture round. . . . → Read More: Neuro Disease Biotech Gains $61M in Early Funds Comments are closed Finance, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, physical sciences, U.K., university, venture capital 
An alliance of academic labs and venture investors is starting a new research enterprise to speed development of treatments for rare diseases in the U.S. and U.K. . . . → Read More: Industry-Academic Center to Boost Rare Disease Therapies Comments are closed Finance, Joint ventures/collaborations biomedical, biotechnology, cancer, genomics, grant, investment, life sciences, pharmaceuticals, U.K., university, venture capital 
A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases. . . . → Read More: University Start-Up Developing Inhaled Gene Therapies 
Results of a clinical trial show a vaccine delivered as a nasal spray protects healthy people against infection from the bacteria causing whooping cough infections. . . . → Read More: Trial Shows Nasal Vaccine Reduces Whooping Cough Bacteria Comments are closed New products biomedical, biotechnology, clinical trials, health care, life sciences, pharmaceuticals, U.K., university 
A health research foundation grant is funding development of a vaccine protecting against typhoid fever, given in a patch from from a spring-loaded device. . . . → Read More: Grant Funds Typhoid Vaccine Patch Development One comment - (Comments are closed) Hiring/layoffs, Joint ventures/collaborations Asia, biomedical, clinical trials, engineering, grant, Korea, life sciences, medical device, pharmaceuticals, preclinical, U.K. 
Findings from two clinical trials show a digital health mobile app helps improve outcomes and manage the conditions for people with depression and asthma. . . . → Read More: Health App Shown to Improve Asthma, Depression Outcomes One comment - (Comments are closed) New products biomedical, clinical trials, engineering, life sciences, mathematics, medical device, physical sciences, psychiatric, software, U.K., university 
A company, spun-off from academic labs that designs and produces new chemicals with artificial intelligence and robotics, is raising $42.7 million in its first venture funding round. . . . → Read More: Digital Chemistry Start-Up Gains $43M in Early Funds One comment - (Comments are closed) Finance, New products biotechnology, chemistry, computer science, engineering, entrepreneurs, equity, investment, life sciences, manufacturing, materials science, mathematics, pharmaceuticals, physical sciences, robotics, software, U.K., university |
||||
|
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts